Investigating how xylazine affects behaviors caused by methamphetamine
Official title: Xylazine effects on methamphetamine-induced behavioral alterations in rats
Funded at Temple Univ of the Commonwealth · NIH-11145507 · Data updated 2026-11-12
This study is looking at how xylazine, which is sometimes mixed with methamphetamine, affects the behavior of rats to help us understand how these substances might make each other worse, and the results could help improve public health efforts related to drug use.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 15, 2025 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $237,750 |
| NIH project number | 1R21DA062400-01A1 |
| Project ID | NIH-11145507 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be individuals struggling with methamphetamine addiction, particularly those who may also be exposed to xylazine.
✕Less likely to help
Patients who are not involved with methamphetamine or xylazine use may not receive any benefit from this research.
What this research studies
This research explores the effects of xylazine, a substance increasingly found in methamphetamine, on behavioral changes in rats. By conducting preclinical studies, the researchers aim to understand how xylazine interacts with methamphetamine and potentially worsens its effects. The study will evaluate various behavioral responses, including locomotor activity and self-administration behaviors, to provide insights into the implications of co-exposure to these substances. The findings could inform public health strategies regarding methamphetamine and xylazine misuse.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for individuals affected by methamphetamine and xylazine co-use.
How similar studies have gone: While there has been limited research on the specific interactions between xylazine and methamphetamine, previous studies have shown some success in understanding the effects of xylazine on other substances.
Where this research is happening
-
Temple Univ of the Commonwealth
Philadelphia, United States Active
Researchers
- Principal investigator: Rawls, Scott M. — Temple Univ of the Commonwealth
- Study coordinator: Rawls, Scott M.
Related research
Other NIH-funded projects on the same topics.
-
Complement in the heart’s microenvironment during renewal
This grant explores how immune signals involving the Complement system help heart cells multiply to repair the heart after a heart attack, with the goal of helping patients recover better.
-
Integrating clinical pharmacists into HIV care to reduce cardiovascular disease in people with HIV
A pharmacist-led program in HIV care aims to prevent and manage heart disease risks like high blood pressure, diabetes, and high cholesterol in people living with HIV.
-
NMDAR-TRPM4 signaling and mitochondria in Alzheimer's disease
Scientists are studying how a specific brain cell signaling pathway (NMDAR-TRPM4) relates to nerve cell damage and memory loss in Alzheimer's disease, using patient-derived stem cell models.
-
Understanding how human chaperone networks affect Alzheimer’s- and dementia-related proteins in yeast
Aims to map how human helper proteins (chaperones) interact with dementia-linked proteins using yeast to find which combinations could prevent harmful protein clumps.
-
CRISPR-based Cure for HIV: Targeting reservoirs and boosting immunity
Aims to use CRISPR gene editing to directly cut HIV provirus and strengthen immune responses so people living with HIV can better control the virus even after stopping therapy.
-
Steric-free labeling to map disease-related protein modifications
A scientist-led study uses advanced labeling tricks to identify disease-related protein modifications in human cells.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.